Following an application from the Institute of Biotechnology, Sera and Vaccines Biomed SA, submitted pursuant to Article 14(1)(b) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of Lactoral on the normal functioning of the alimentary tract (Question No EFSA-Q-2008-269) [The EFSA Journal (2008) 861, pp. 1-9.]. The claim proposed by the applicant was worded as follows: ‘Lactoral helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example, in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens)’.
Recital 13, Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refu…
In forcesince 29 Oct 2009